Business NewsPR NewsWire • R-Tech Ueno Submits Request for Arbitration against Takeda Pharmaceutical

R-Tech Ueno Submits Request for Arbitration against Takeda Pharmaceutical

R-Tech Ueno Submits Request for Arbitration against Takeda Pharmaceutical

TOKYO, Aug. 16 /PRNewswire/ -- R-Tech Ueno, Ltd., together with Sucampo Pharmaceuticals, Inc. ("Sucampo") and Sucampo AG ("SAG"), has requested arbitration against Takeda Pharmaceutical Co. Ltd. ("Takeda"). R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and

View More : http://www.prnewswire.com/news-releases/r-tech-ueno-submits-request-for-arbitration-against-takeda-pharmaceutical-100746...
Releted News by prnewswire
Arizona Startup Empowers Businesses to Convert More Web Leads to Sales Faster
Rising Burden of Diseases Drives the Pharmaceutical Industry in East Africa, Says Frost & Sullivan
African Steam Turbine Market Set to Grow Amidst Rising Electricity Demand, Notes Frost & Sullivan
R-Tech Ueno Submits Request for Arbitration against Takeda Pharmaceutical
Webcast Alert: Companhia de Transmissao de Energia Eletrica Paulista - CTEEP Announces Second Quarter 2010 Earnings Conference Call Webcast
China Power Equipment Reports Higher Revenues and Net Income
HTG Peer Groups Welcomes First Australian Members